Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

FSAD Study

Phase 2, Randomized, Double-blind, Placebo controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects with Female Sexual Arousal Disorder

couple holding hands
AGE: 40 -65 years old
SEX AT BIRTH: Female
HEALTHY PARTICIPANTS: Yes
TYPE: Interventional Study
CONDITION: Female Sexual Arousal Disorder (FSAD)
LOCATIONS: UH Landerbrook Medical Center

Learn More About This Research Study

Please contact the study coordinator, Bridget Ermlich, RN, MSN, at 216-844-8091 or complete the online form below below for more information.

Study Purpose

The purpose of this study is to determine if an investigational treatment may improve some of the symptoms associated with Female Sexual Arousal Disorder (FSAD) in postmenopausal women (who have had a hysterectomy), such as vaginal dryness and swelling and genital pain that occurs just before, during or after sexual intercourse. The treatment part of the study will last 12 weeks (84 days). The total study participation time may be up to 30 weeks.

Who Can Participate

Women 40-65 years old with FSAD may be eligible for this study.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study,

I'm not a robot